Sorry, you do not have access to this eBook
A subscription is required to access the full text content of this book.
Metrics
Views
217
In This Chapter
Abstract
Most methods for sequentially adaptive dose-finding in phase I clinical trials characterize outcome as an indicator yt of toxicity and assume that patients are homogeneous. This entry reviews a new method which requires an informative prior on covariate effect parameters, obtained from historical data.
Other ways to access this content:
Email to request access
Purchase this book
Related chapters
Search for more...
© Informa UK Limited, an Informa Group Company
Home | About RHO | Collections
| Free trial
| How to buy
| Promotions
| Contact us | Help & FAQs
Librarian resources
| Privacy policy
| Cookies
| Terms & conditions
